July 29 2013 | By Márcio Barra
Paulo Lilaia, president of APOGEN
Portuguese generic drug makers will now be able to introduce new generic drugs into the market every month and not just quarterly, in another move by the Portuguese Ministry of Health to increase the market share of generics and reduce state drug expenditure.
Ordinance n.º 103/2013 from 26 July 2013 , changes “the mechanisms of creation of homogeneous groups and respective reference prices, aiming to maximize savings resulting from a greater incentive for generics use and promote an increase of market share in line with the international commitments of the Portuguese State, “reads the preamble of the statute. This ordinance updates Decree-Law n. -A/2010 48, already amended by Decree-Law n.º 106 -A/2010 and Law n. º 62/2011.
According to the Ordinance, the calculation and publication of the reference price of new homogeneous groups created as a result of the market introduction of new generic drugs has to be published by the twentieth day of each month. Until now, these approvals only occurred once every three months.
Paulo Lilaia, president of the Portuguese Association of Generic (Apogen), applauds the measure , requested for a long time by Apogen. “With these changes, entry of generic drugs in the market can happen faster and in a greater number. It’s good for the industry, for the National Health system and for users, “he concluded in declarations to the Jornal de Negócios (in Portuguese)
For more on Drug pricing in Portugal, please check this article.